Saturday, August 20, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Chemistry AND Physics

InSilico Medicine Presents advances in deep learning for drug discovery and aging research

January 11, 2016
in Chemistry AND Physics
0
Share on FacebookShare on Twitter

Aging research is a very controversial area with many failed claims and promises and in order to establish the proof of concept of its approach, InSilico Medicine decided to build a sustainable business model providing pathway activation analysis and machine learning services to pharmaceutical companies, academic and clinical institutions helping drive innovation in many areas of research.

"Our mission is to extend healthy human longevity and we spent several years developing a sustainable model to enable the company to effectively use massive heterogeneous biological data sets for drug discovery, biomarker development and personalized medicine. With over 20 academic publications published in 2015 and over 150 collaborators worldwide, we are very excited to present our results that will lead to faster and more effective diagnostics and cures in many age-related diseases", said Alex Zhavoronkov, PhD, Chief Executive Officer of InSilico Medicine, Inc and Chief Science Officer of the Biogerontology Research Foundation.

Deep learning technologies resulted in major breakthroughs in image, voice and text recognition, autonomous driving, networking and mobile applications surpassing human accuracy and demonstrating unprecedented results. However, in genomic and transcriptomic analysis, drug discovery and repurposing and many other areas of biomedicine, progress has been much slower. Since November 2014 InSilico Medicine decided to shift its focus on and commit to deep learning technologies despite many early failures showing superiority of other machine learning techniques.

"When it comes to training deep neural networks with transcriptomic and other types of biological data many groups notice the superiority of advanced implementations of SVM, GBM and other machine learning methods. However, there is much to be learned from the inaccuracies of the DNNs that will lead to both new methods to working with biological data and provide clues on alternative uses of drugs particularly when it comes to age-related diseases. Several of our collaborators in the pharmaceutical and cosmetics industries are already testing these methods and I am happy to be part of the team that will establish more of these collaborations during the J.P. Morgan conference", said Polina Mamoshina, research scientist, InSilico Medicine.

###

About InSilico Medicine, Inc

InSilico Medicine, Inc. is a bioinformatics company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore. It utilizes advances in genomics, big data analysis and deep learning for in silico drug discovery and drug repurposing for aging and age-related diseases. The company pursues internal drug discovery programs in cancer, Parkinson's, Alzheimer's, sarcopenia and geroprotector discovery and provides services to pharmaceutical companies. Brief company video: https://www.youtube.com/watch?v=l62jlwgL3v8

Media Contact

Qingsong Zhu
[email protected]
443-451-7212
@InSilicoMeds

http://www.insilicomedicine.com

Share25Tweet16Share4ShareSendShare
  • Fig1_EcosystemReconstruction(Credit_HenrySharpe).png

    Global warming spawned the age of reptiles

    70 shares
    Share 28 Tweet 18
  • 60 million years of climate change drove the evolution and diversity of reptiles

    68 shares
    Share 27 Tweet 17
  • In wine, there’s health: Low levels of alcohol good for the brain

    67 shares
    Share 26 Tweet 17
  • New insights on how some individuals with obesity can lose weight – and keep it off

    70 shares
    Share 28 Tweet 18
  • UArizona Cancer Center receives highest NCI designation as Comprehensive Cancer Center

    68 shares
    Share 27 Tweet 17
  • Climate change may cause steeper wheat price spikes and economic inequality

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Reinvigorating ‘lost cause’ exhausted T cells could improve cancer immunotherapy

Allison Institute announces formation of scientific advisory board

How quinine caused World War I (hyperbolic title alert) (video)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 194 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In